Anti-Human IFNA1 Recombinant Antibody (Sifalimumab)

CAT#: TAB-H62

Recombinant human antibody to Human IFNA1. Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.

Published Data Gene Expression
Figure 1 Pharmacokinetics (PK) and pharmacodynamics of sifalimumab over time in patients with systemic lupus erythematosus (PK population). Figure 2 Change from baseline in disease activity.
Figure 1 RNA cell line category: Cell line enhanced (HeLa, hTERT-RPE1)

Specifications

  • Host Species
  • human
  • Derivation
  • human
  • Type
  • IgG1 - kappa
  • Specificity
  • IFNA1 (interferon alpha 1, IFN-alpha, IFN alpha 1/13, IFN 13) [Homo sapiens]
  • Species Reactivity
  • Human
  • Applications
  • ELISA, Inhib
  • CAS
  • 1006877-41-3
  • Generic Name
  • sifalimumab
  • UNII
  • XOY1YA7RMC
  • MW
  • 146.25 kDa
  • Related Disease
  • Systemic lupus erythematosus (SLE)

Product Property

  • Purity
  • >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.

Applications

  • Application Notes
  • The IFNA1 antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Inhibition.

Target

  • Alternative Names
  • sifalimumab;1006877-41-3;IFNA1;interferon, alpha 1;interferon alpha-1/13;IFL;IFN;IFN ALPHA;IFN alpha 1b;IFN alphaD;IFNA13;IFNA@;interferon alpha 1b;leIF D;IFN-alpha 1b;IFN-alpha-1/13;interferon-alpha1;interferon alpha-D;IFN-ALPHA;IFN-alphaD;MGC138207;MGC1
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-H62. Click the button above to contact us or submit your feedback about this product.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-H62, RRID: AB_3112039)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Sifalimumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Sifalimumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "Sifalimumab"

Afuco™ Anti-IFNA1 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H62)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human antibody to Human IFNA1. It is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.
DrugMonitor™ Anti-Sifalimumab Antibody (VS-1224-YC1087)
Sifalimumab is a fully human monoclonal antibody targeting interferon-alpha, potentially suppressing abnormal immune activity in lupus by binding to multiple interferon-alpha subtypes. The DrugMonitor™ Anti-Sifalimumab Antibody (VS-1224-YC1087) is an anti-drug antibody (ADA) against Sifalimumab. This drug-based antibody is raised in mice immunized with the Sifalimumab. The anti-Sifalimumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Sifalimumab in samples.

See other products for "IFNA1"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
TAB-074 Anti-Human IFN alpha Recombinant Antibody (TAB-074) WB IgG1 - kappa
CAT Product Name Application Type
TAB-747 Anti-IFNA1 Recombinant Antibody (Faralimomab) FuncS, IF, Neut, ELISA, FC, IP, IHC IgG1
CAT Product Name Application Type
MOR-4599 Rabbit Anti-IFNA1 Recombinant Antibody (clone TH112DS) WB Rabbit IgG
CAT Product Name Application Type
AFC-TAB-747 Afuco™ Anti-IFNA1 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-747) FuncS, IF, Neut, ELISA, FC, IP ADCC enhanced antibody
AFC-TAB-074 Afuco™ Anti-IFNA1 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-074) ELISA, FC, IP, FuncS, IF, Neut ADCC enhanced antibody
AFC-TAB-H62 Afuco™ Anti-IFNA1 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H62) IP, IF, FuncS, FC, Neut, ELISA ADCC enhanced antibody
CAT Product Name Application Type
VS-0425-FY118 Human Anti-IFNA1 scFv-Fc Chimera (VS-0425-FY118) ELISA, Inhib Human IgG1, scFv-Fc
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare